Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company. The company has entered into several co-discovery agreements to expand its portfolio and has also signed license agreements for its transgenic mouse platforms with select partners to further Next-Gen drug invention.
友情链接:竞彩足球投注  时代娱乐  云顶国际4008  月博老虎机  盈盈彩票登录  皇家国际客服  合乐娱乐登录  亚洲必赢app平台